Skip to content

Vibration and balance training in breast cancer patients during radiotherapy - pilot study

Vibration and balance training in breast cancer patients during radiotherapy - pilot study - ViBBRa-pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004862
Enrollment
20
Registered
2013-04-26
Start date
2013-05-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50

Interventions

Group 1: Intervention for intervention group 3x/week over 6 weeks, 1 hour per training session: handheld vibration training with Galileo® UpX Dumbbell (3x5 exercises, 20min), balance training (3-6 exe

Sponsors

Medizinische Universitätsklinik Freiburg Abtl. Hämatologie/Onkologie
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - breast cancer patients undergoing adjuvant radiotherapy (with or without lymphatic pathways) - Age =18 years - Performance- Status Karnofsky- Index >60 - Signed informed consent

Exclusion criteria

Exclusion criteria: Absolute: - Instable bone metastases - Myocardial infarction, Angina pectoris or heart disease (NYHA III-IV) in a time period of six months - Arterial hypertension, which is not treated adequately (in therapy >180mmHg systolic; >100mmHg diastolic) - Patients with an increased risk for thrombosis besides underlying disease Relative (inclusion or continuation after recovery possible): - Acute infection (=38,0°Celcius and/ or intravenously therapy with antibiotics) - Thrombocytes < 10x10^9/L - Leukocytes < 1x10^9/L - Hb < 8g/dl

Design outcomes

Primary

MeasureTime frame
performed exercise sessions of IG compared to state of the art [%] (feasibilty of handheld vibration and balance training during radiotherapy)

Secondary

MeasureTime frame
Secondary endpoint will be assessed pre and post intervention (before radiation therapy and after 6 weeks with termination of radiation therapy) Lymphedema (volume in cm3), postural control (sway path of center of force (COF) in cm), mobility (sec in chair-rising-test), endurance capacity (watt at individual anaerobic threshold (IAT)), quality of life (EORCT-QLQ-C30), fatigue (MFI)

Countries

Germany

Contacts

Public ContactSarah Kneis

Universitätsklinik Freiburg Klinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation

sarah.kneis@uniklinik-freiburg.de0761 270-73240

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026